Julie Cooke is CHRO at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 16 open-market trades across 1 company since 2019, most recently 2026-09-11.
CIK 0001776977
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NBIX | 24,025 | $4.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL · 10b5-1 | 2026-06-02 | 2026-06-04 | $156.22 | $5.8M | -6.0% | +4.6% | -5.2% |
| NBIX | SELL · 10b5-1 | 2025-02-13 | 2025-02-14 | $116.78 | $274K | +2.2% | -3.1% | +4.6% |
| NBIX | SELL · 10b5-1 | 2025-02-10 | 2025-02-12 | $118.28 | $83K | -1.2% | -5.6% | -0.4% |
| NBIX | SELL · 10b5-1 | 2025-01-31 | 2025-02-04 | $152.89 | $532K | -24.2% | -25.7% | -27.6% |
| NBIX | SELL · 10b5-1 | 2024-08-01 | 2024-08-05 | $153.26 | $3.9M | +0.0% | -17.0% | -18.4% |
| NBIX | SELL · 10b5-1 | 2024-07-16 | 2024-07-18 | $150.04 | $135K | -2.3% | +2.6% | -18.1% |
| NBIX | SELL · 10b5-1 | 2024-07-01 | 2024-07-02 | $140.19 | $1.4M | +6.8% | +10.9% | -16.6% |
| NBIX | SELL · 10b5-1 | 2024-02-13 | 2024-02-15 | $133.04 | $212K | +0.4% | +3.9% | +5.9% |
| NBIX | SELL · 10b5-1 | 2024-02-06 | 2024-02-08 | $138.90 | $530K | -3.0% | +2.9% | +3.2% |
| NBIX | SELL · 10b5-1 | 2024-01-31 | 2024-02-02 | $141.29 | $492K | -6.7% | -5.7% | -1.0% |
| NBIX | SELL · 10b5-1 | 2023-12-22 | 2023-12-27 | $129.15 | $4.9M | +0.8% | +7.2% | +6.4% |
| NBIX | SELL · 10b5-1 | 2023-09-01 | 2023-09-06 | $110.93 | $183K | +1.2% | +3.0% | +7.1% |
| NBIX | SELL · 10b5-1 | 2023-08-21 | 2023-08-23 | $107.41 | $458K | +2.1% | +5.6% | +1.8% |
| NBIX | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $103.89 | $2.4M | -0.7% | -6.6% | +4.6% |
| NBIX | SELL · 10b5-1 | 2023-04-25 | 2023-04-27 | $103.82 | $10K | -4.0% | -11.0% | -0.9% |
| NBIX | SELL | 2023-02-06 | 2023-02-08 | $102.72 | $3.4M | -2.5% | -8.5% | -7.2% |
| NBIX | SELL | 2023-01-31 | 2023-02-02 | $108.48 | $199K | -5.8% | -7.8% | -9.8% |
| NBIX | SELL | 2022-11-08 | 2022-11-10 | $124.99 | $1.4M | -1.7% | -2.8% | -15.0% |
| NBIX | SELL | 2022-11-02 | 2022-11-04 | $124.99 | $1.2M | -7.7% | +1.6% | -11.5% |
| NBIX | SELL | 2022-08-05 | 2022-08-09 | $100.00 | $182K | -0.9% | -1.2% | +12.1% |
| NBIX | SELL | 2022-06-27 | 2022-06-29 | $100.00 | $75K | -2.1% | -3.3% | +4.2% |
| NBIX | SELL | 2022-02-07 | 2022-02-09 | $80.49 | $355K | +10.7% | +12.7% | +3.8% |
| NBIX | SELL | 2021-10-04 | 2021-10-06 | $101.73 | $201K | +1.7% | -8.9% | -15.3% |
| NBIX | SELL | 2021-02-05 | 2021-02-09 | $115.72 | $401K | -4.3% | -18.5% | -21.3% |
| NBIX | SELL | 2020-11-12 | 2020-11-16 | $90.73 | $410K | +3.1% | +6.5% | +21.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.